Encompass Health Corporation (EHC) Income Statement
EHC 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsEHC revenue and net income
Where EHC's revenue goes
2025Each bar shows an amount and its share of revenue. EHC kept 9.5% of revenue as net income.
EHC profit margins
EHC growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +10.5% | +10.9% | +10.7% | +6.7% |
| Gross profit | +14.9% | +13.5% | −5.5% | −1.5% |
| Operating income | +21.8% | +18.7% | +9.7% | +6.6% |
| Net income | +24.2% | +27.8% | +14.8% | +12.0% |
| EPS (diluted) | +23.3% | +17.0% | +13.6% | +9.7% |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
EHC quarterly EPS vs estimates
Encompass Health beat the analyst EPS estimate in 8 of the last 8 quarters. Next report: October 28, 2026 (estimate $1.37).
EHC income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.94B | $5.37B | $4.80B | $4.35B | $4.01B | $3.57B | $4.61B | $4.28B | $3.91B | $3.64B |
| Cost of revenue | $3.37B | $3.14B | $2.82B | $2.60B | $2.31B | $171.0M | $167.9M | $158.7M | $149.3M | $140.0M |
| Gross profit | $2.56B | $2.23B | $1.98B | $1.75B | $1.70B | $3.40B | $4.44B | $4.12B | $3.76B | $3.50B |
| Research & development | — | — | — | — | — | — | — | $0 | $0 | $0 |
| Sales, general & admin | $295.2M | $266.5M | $314.3M | $209.0M | $228.5M | $2.12B | $2.90B | $2.65B | $2.40B | $2.19B |
| Total operating expenses | $1.51B | $1.37B | $1.25B | $1.12B | $1.04B | $3.40B | $4.44B | $4.12B | $3.76B | $3.50B |
| Operating income | $1.05B | $864.5M | $731.8M | $630.2M | $659.4M | $661.9M | $692.5M | $681.6M | $649.4M | $648.8M |
| Interest income | $118.9M | $134.4M | $140.3M | $172.8M | $160.6M | $180.7M | $153.0M | $138.6M | $146.4M | $162.3M |
| Interest expense | $123.2M | $137.4M | $143.5M | $175.7M | $164.3M | $183.7M | $159.7M | $147.3M | $154.4M | $172.1M |
| Income before taxes | $953.0M | $749.6M | $607.2M | $450.8M | $505.0M | $352.9M | $562.3M | $493.2M | $496.4M | $482.0M |
| Income taxes | $192.9M | $150.2M | $132.2M | $100.1M | $101.9M | $74.7M | $115.9M | $118.9M | $145.8M | $163.9M |
| Net income | $566.2M | $455.7M | $352.0M | $271.0M | $412.2M | $284.2M | $358.7M | $292.3M | $271.1M | $247.6M |
| EBITDA | $1.40B | $1.19B | $1.02B | $870.1M | $888.9M | $739.6M | $940.7M | $840.2M | $834.6M | $826.7M |
| EPS (diluted) | $5.46 | $4.43 | $3.64 | $3.41 | $4.22 | $2.89 | $3.90 | $3.63 | $2.77 | $2.67 |
| Gross margin | 43.2% | 41.6% | 41.3% | 40.3% | 42.4% | 95.2% | 96.4% | 96.3% | 96.2% | 96.2% |
| Operating margin | 17.7% | 16.1% | 15.2% | 14.5% | 16.4% | 18.6% | 15.0% | 15.9% | 16.6% | 17.8% |
| Net margin | 9.5% | 8.5% | 7.3% | 6.2% | 10.3% | 8.0% | 7.8% | 6.8% | 6.9% | 6.8% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.60B | $1.59B | $1.54B | $1.48B | $1.46B | $1.46B | $1.41B | $1.35B | $1.30B | $1.32B | $1.25B | $1.21B |
| Cost of revenue | $886.4M | $882.4M | $865.6M | $849.4M | $830.8M | $824.5M | $819.1M | $792.7M | $758.1M | $770.1M | $734.9M | $712.5M |
| Gross profit | $711.0M | $704.2M | $679.0M | $628.1M | $626.9M | $630.9M | $585.9M | $558.3M | $543.1M | $545.9M | $511.9M | $494.4M |
| Sales, general & admin | $77.3M | $73.4M | $82.9M | $71.0M | $74.1M | $82.1M | $83.9M | $68.4M | $64.7M | $64.2M | $67.1M | $64.0M |
| Total operating expenses | $422.6M | $402.6M | $395.6M | $384.5M | $367.8M | $363.9M | $353.6M | $349.2M | $327.5M | $338.4M | $67.1M | $64.0M |
| Operating income | $288.4M | $301.6M | $283.4M | $243.6M | $259.1M | $267.0M | $232.3M | $209.1M | $215.6M | $207.5M | $444.8M | $430.4M |
| Interest income | — | — | $29.4M | $29.6M | $29.0M | $30.9M | $32.8M | $34.2M | — | — | — | $34.9M |
| Interest expense | $32.8M | $31.8M | $30.2M | $30.8M | $30.4M | $31.8M | $33.0M | $34.9M | $34.3M | $35.2M | $34.9M | $35.9M |
| Income before taxes | $261.6M | $288.7M | $257.7M | $219.9M | $236.8M | $238.6M | $201.4M | $183.8M | $186.0M | $178.4M | $164.8M | $145.0M |
| Income taxes | $53.6M | $56.4M | $55.4M | $44.9M | $51.0M | $41.6M | $37.6M | $36.0M | $38.3M | $38.3M | $37.2M | $30.3M |
| Net income | $153.9M | $194.5M | $146.1M | $126.5M | $142.1M | $151.5M | $120.9M | $108.2M | $114.1M | $112.5M | $87.6M | $85.3M |
| EBITDA | $384.8M | $407.8M | $374.3M | $333.1M | $347.1M | $349.6M | $312.4M | $297.1M | $293.2M | $283.9M | $260.0M | $246.7M |
| EPS (diluted) | $1.55 | $1.60 | $1.46 | $1.23 | $1.40 | $1.37 | $1.17 | $1.03 | $1.11 | $1.12 | $0.95 | $0.86 |
| Gross margin | 44.5% | 44.4% | 44.0% | 42.5% | 43.0% | 43.3% | 41.7% | 41.3% | 41.7% | 41.5% | 41.1% | 41.0% |
| Operating margin | 18.1% | 19.0% | 18.3% | 16.5% | 17.8% | 18.3% | 16.5% | 15.5% | 16.6% | 15.8% | 35.7% | 35.7% |
| Net margin | 9.6% | 12.3% | 9.5% | 8.6% | 9.7% | 10.4% | 8.6% | 8.0% | 8.8% | 8.5% | 7.0% | 7.1% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in EHC's financial statements (latest annual report filed February 26, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
EHC financial results
In fiscal year 2025 (ended December 31, 2025), Encompass Health reported revenue of $5.9 billion, up 10.5% from the year before. It had net income of $566.2 million (up 24.2%), a net profit margin of 9.5%. Diluted earnings per share came to $5.46. Over five years revenue grew at an average rate of 10.7% a year.
See the EHC stock overview for the latest quote and news, or the EHC chart for price history and technical indicators.
EHC income statement FAQ
What is Encompass Health's annual revenue?
Encompass Health reported total revenue of $5.9 billion for fiscal year 2025, which ended on December 31, 2025. That was up 10.5% from $5.4 billion the previous year.
Is Encompass Health profitable?
Yes. Encompass Health reported net income of $566.2 million in fiscal 2025, a net profit margin of 9.5%; its operating margin was 17.7%.
What is Encompass Health's gross margin?
Encompass Health's gross margin was 43.2% in fiscal 2025: for every $100 of revenue, Encompass Health kept $43 after the direct cost of its products and services.
How fast is Encompass Health growing?
Revenue grew 10.7% a year on average over the last five fiscal years, from $3.6 billion to $5.9 billion.
What are Encompass Health's earnings per share?
Encompass Health earned $5.46 per diluted share in fiscal 2025, compared with $4.43 a year earlier.
When will Encompass Health report its next earnings?
Encompass Health is expected to report results for the quarter ending September 30, 2026 on October 28, 2026 after the market closes.
When does Encompass Health's fiscal year end?
Encompass Health's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on February 26, 2026.